We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+1.75%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.32B
AUM Growth
+$18.4M
Cap. Flow
+$63.1M
Cap. Flow %
4.78%
Top 10 Hldgs %
33.66%
Holding
527
New
34
Increased
323
Reduced
125
Closed
25

Top Buys

Rank Stock Value
1
IAU icon
iShares Gold Trust
IAU
+$29.1M
2
GLD icon
SPDR Gold Trust
GLD
+$19.8M
3
WMT icon
Walmart Inc
WMT
+$17M
4
GLDM icon
SPDR Gold MiniShares Trust
GLDM
+$13.8M
5
AMAT icon
Applied Materials
AMAT
+$4.96M

Top Sells

Rank Stock Value
1
UGL icon
ProShares Ultra Gold
UGL
+$12.5M
2
AZN icon
AstraZeneca
AZN
+$8.14M
3
AVGO icon
Broadcom
AVGO
+$5.93M
4
MSFT icon
Microsoft
MSFT
+$4.33M
5
APH icon
Amphenol
APH
+$3.63M

Sector Composition

Rank Sector Weight
1 Technology 35.21%
2 Healthcare 22.82%
3 Communication Services 11.05%
4 Consumer Discretionary 8.42%
5 Consumer Staples 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
A icon
276
Agilent Technologies
A
$41.9B
$411K 0.03%
3,600
+1,100
+44% +$140K
WRD
277
WeRide Inc
WRD
$1.88B
$405K 0.03%
50,000
+10,000
+25% +$77.4K
ON icon
278
ON Semiconductor
ON
$32.4B
$402K 0.03%
6,500
+4,000
+160% +$251K
ADPT icon
279
Adaptive Biotechnologies
ADPT
$4.02B
$401K 0.03%
28,925
+2,448
+9% +$39K
CRVS icon
280
Corvus Pharmaceuticals
CRVS
$1.27B
$397K 0.03%
27,155
+8,986
+49% +$143K
DAWN
281
DELISTED
Day One Biopharmaceuticals
DAWN
$393K 0.03%
18,331
+1,600
+10% +$22.5K
KNSA icon
282
Kiniksa Pharmaceuticals
KNSA
$6.1B
$392K 0.03%
8,145
+786
+11% +$34.8K
TRVI icon
283
Trevi Therapeutics
TRVI
$2.53B
$391K 0.03%
32,755
+11,860
+57% +$133K
HSAI
284
Hesai Group
HSAI
$2.99B
$382K 0.03%
20,000
– –
DFTX
285
Definium Therapeutics
DFTX
$5.75B
$382K 0.03%
20,192
+4,140
+26% +$70.3K
ADMA icon
286
ADMA Biologics
ADMA
$2.19B
$381K 0.03%
42,263
+3,481
+9% +$54.9K
MLYS icon
287
Mineralys Therapeutics
MLYS
$2.39B
$380K 0.03%
14,044
+1,148
+9% +$33.7K
RAPP
288
Rapport Therapeutics
RAPP
$2.29B
$377K 0.03%
12,058
+1,292
+12% +$36.3K
RGEN icon
289
Repligen
RGEN
$9.35B
$377K 0.03%
3,200
-400
-11% -$55.9K
DSGN icon
290
Design Therapeutics
DSGN
$917M
$374K 0.03%
35,109
+827
+2% +$8.37K
ELV icon
291
Elevance Health
ELV
$86.6B
$366K 0.03%
1,250
-750
-38% -$246K
SNDX icon
292
Syndax Pharmaceuticals
SNDX
$1.77B
$366K 0.03%
15,652
+1,489
+11% +$32.4K
TYRA icon
293
Tyra Biosciences
TYRA
$1.51B
$363K 0.03%
9,471
+774
+9% +$25.1K
RARE icon
294
Ultragenyx Pharmaceutical
RARE
$2.65B
$359K 0.03%
17,148
+1,427
+9% +$32.1K
MAZE
295
Maze Therapeutics
MAZE
$1.53B
$358K 0.03%
11,995
+554
+5% +$24.4K
AGIO icon
296
Agios Pharmaceuticals
AGIO
$2.04B
$352K 0.03%
10,398
+896
+9% +$25.4K
ZETA icon
297
Zeta Global
ZETA
$7.17B
$350K 0.03%
22,000
– –
AUPH icon
298
Aurinia Pharmaceuticals
AUPH
$2.06B
$350K 0.03%
23,597
+2,114
+10% +$30.9K
ANAB icon
299
AnaptysBio
ANAB
$1.69B
$342K 0.03%
6,164
-1,348
-18% -$72.5K
PODD icon
300
Insulet
PODD
$10.1B
$336K 0.03%
1,600
+1,000
+167% +$251K
10 11
12
13 14

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q1 2026 Portfolio in Review

As of Q1 2026, China Universal Asset Management Company held 527 positions worth $1.32B, up 1.4% from $1.3B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

China Universal Asset Management Company deployed $63.1M of net new capital in Q1 2026, opening 34 new positions and adding to 323 existing holdings. Its largest new stake was TJX Companies: 13,200 shares worth $2.11M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 38% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was ProShares Ultra Gold, an estimated $12.5M trimmed.

  • China Universal Asset Management Company's largest Q1 2026 buy was TJX Companies: 13,200 shares worth $2.11M.
  • China Universal Asset Management Company added most to iShares Gold Trust in Q1 2026, an estimated $29.1M increase.
  • China Universal Asset Management Company's biggest Q1 2026 reduction was ProShares Ultra Gold, cutting an estimated $12.5M.
  • China Universal Asset Management Company fully exited ServiceNow in Q1 2026, selling an estimated $2.5M.
  • China Universal Asset Management Company's ten largest holdings make up 34% of its $1.32B portfolio in Q1 2026.
  • China Universal Asset Management Company opened 34 new positions and closed 25 in Q1 2026.
  • China Universal Asset Management Company's portfolio value rose 1.4% quarter-over-quarter to $1.32B.

Based on China Universal Asset Management Company's 13F filing for Q1 2026, filed 28 Apr 2026.